Application Research of Platelet-Derived Growth Factor (PDGF) in Cell Proliferation, Vascular Remodeling, and Tissue Repair
Application Research of Platelet-Derived Growth Factor (PDGF) in Cell Proliferation, Vascular Remodeling, and Tissue Repair
Platelet-derived growth factor (PDGF) is a class of disulfide-linked dimeric growth factors. It was originally named because it is present in platelet α-granules and is released after platelet activation. PDGF can promote the proliferation, migration, and chemotaxis of smooth muscle cells, fibroblasts, connective tissue cells, bone- and cartilage-related cells, and other cell types. It plays important roles in tissue repair, vascular maturation, embryonic development, neural development, and fibrosis.
Keywords: PDGF; platelet-derived growth factor; PDGFR; PDGF-AA; PDGF-BB; pericytes; fibroblasts; smooth muscle cells; tissue repair; fibrosis
1 Basic Characteristics of PDGF
1.1 Structural Composition of PDGF
PDGF belongs to the VEGF/PDGF-related growth factor family. Its typical structural feature is the presence of conserved cysteine residues and the formation of dimers through disulfide bonds. The PDGF family includes four polypeptide chains: PDGF-A, PDGF-B, PDGF-C, and PDGF-D. These chains can form dimeric forms such as PDGF-AA, PDGF-BB, PDGF-AB, PDGF-CC, and PDGF-DD.
(1) Homodimers
PDGF-AA, PDGF-BB, PDGF-CC, and PDGF-DD are composed of identical polypeptide chains. Different homodimers vary in their binding capacity for PDGFR-α and PDGFR-β, which determines their target cell types and biological effects.
(2) Heterodimer
PDGF-AB is composed of an A chain and a B chain and has partial activities related to both PDGF-A and PDGF-B. It can participate in cell chemotaxis, proliferation, and tissue repair-related responses.
(3) Active forms
PDGF-C and PDGF-D usually require proteolytic processing to form mature active structures. Therefore, when studying these two members, the distinction among precursor protein, mature protein, and receptor activation status should be considered.
1.2 Sources of PDGF
PDGF is not only derived from platelets, but can also be produced by endothelial cells, macrophages, fibroblasts, vascular smooth muscle cells, tumor cells, and various stromal cells. After platelet activation, PDGF is released and can form a high-concentration growth factor environment at the injury site, promoting cell recruitment, migration, matrix remodeling, and repair responses.
1.3 Functional Differences Between PDGF and VEGF
PDGF and VEGF both belong to dimeric growth factor-related families, but their functional emphasis differs. VEGF mainly acts on vascular endothelial cells and promotes endothelial cell proliferation, migration, vascular permeability, and angiogenesis. PDGF preferentially acts on fibroblasts, vascular smooth muscle cells, and pericytes, and participates in vascular wall support, stromal cell expansion, tissue repair, and fibrosis. In vascular structure research, VEGF is more commonly used to explain “new blood vessel formation,” whereas PDGF-BB/PDGFR-β is more commonly used to explain “pericyte recruitment and vascular maturation.”
Table 1 PDGF Family Members and Receptor Selectivity
PDGF Member | Structural Form | Main Source or Expression | Main Function | Main Receptor |
PDGF-AA | Homodimer | Platelets, fibroblasts, development-related tissues | Fibroblast proliferation, chemotaxis, embryonic development, tissue repair | PDGFR-αα |
PDGF-BB | Homodimer | Platelets, endothelial cells, vascular smooth muscle cells, some tumor cells | Smooth muscle cell proliferation, pericyte recruitment, vascular maturation, fibrosis | PDGFR-αα, PDGFR-αβ, PDGFR-ββ |
PDGF-AB | Heterodimer | Platelet α-granules, injury repair-related microenvironment | Mitogenic activity, chemotaxis, tissue repair | PDGFR-αα, PDGFR-αβ |
PDGF-CC | Homodimer | Retinal pigment epithelium, kidney, reproductive system, stromal cells | Embryonic development, angiogenesis, tissue remodeling | PDGFR-αα, PDGFR-αβ |
PDGF-DD | Homodimer | Heart, pancreas, adrenal gland, liver, kidney, reproductive system | Smooth muscle cell response, vascular remodeling, fibrosis | PDGFR-ββ |
2 PDGF Receptors and Mechanisms of Action
2.1 PDGFR-α and PDGFR-β
PDGF mainly acts through two receptor tyrosine kinases, PDGFR-α and PDGFR-β. After ligand binding, the receptors undergo dimerization and activate intracellular tyrosine kinase domains, leading to receptor tyrosine autophosphorylation and recruitment of downstream signaling proteins.
(1) PDGFR-α
PDGFR-α can respond to PDGF-AA, PDGF-AB, PDGF-BB, and PDGF-CC. It is commonly associated with fibroblast activation, stromal cell proliferation, embryonic development, and oligodendrocyte precursor cell-related research.
(2) PDGFR-β
PDGFR-β mainly responds to PDGF-BB and PDGF-DD and can also participate in PDGF-AB-related responses. It is commonly found in pericytes, vascular smooth muscle cells, and some fibrosis models.
(3) Receptor combinations
Different PDGF ligands induce different receptor dimers. PDGF-AA mainly activates PDGFR-αα, PDGF-DD preferentially activates PDGFR-ββ, and PDGF-BB has a broader range of activity. Therefore, experimental design should first confirm whether the target cells express PDGFR-α or PDGFR-β before selecting the corresponding PDGF ligand.
2.2 Cellular Responses After PDGF Receptor Activation
After PDGF binds to PDGFR, multiple downstream branches can participate in cellular responses, including RAS/MAPK, PI3K/AKT, PLCγ/PKC, Src/FAK, and STAT-related mechanisms. These downstream mechanisms should not be interpreted separately from cellular phenotypes, but should be linked to functional outcomes such as proliferation, migration, chemotaxis, matrix production, or vascular maturation.

Figure 1 Schematic diagram of PDGF receptor signaling crosstalk
(1) RAS/MAPK branch
This branch mainly participates in cell proliferation, differentiation, and transcriptional regulation. Increased p-ERK after PDGF stimulation often suggests that cells have entered a proliferative or stress-responsive state, but EdU, Ki-67, or cell cycle assays are still needed for confirmation.
(2) PI3K/AKT branch
This branch mainly affects cell survival, migration, and anti-apoptotic responses. PDGF-BB-induced smooth muscle cell migration, pericyte survival, and fibroblast activation are often accompanied by enhanced AKT phosphorylation.
(3) PLCγ/PKC/Ca²⁺ branch
This branch mainly participates in Ca²⁺ changes, cytoskeletal remodeling, and migration responses. It is suitable for explaining PDGF-induced chemotaxis, morphological changes, and local cell movement.
(4) Src/FAK branch
This branch mainly participates in focal adhesion turnover, cytoskeletal remodeling, migration, and invasion. In PDGF-induced migration, p-FAK, p-Src, Paxillin, and cytoskeletal staining better reflect the motile phenotype than p-ERK alone.
Table 2 Major Downstream Mechanisms Mediated by PDGF Receptors
Downstream Mechanism | Representative Molecules | Main Function | Common Interpretation Indicators |
RAS/MAPK | RAS, RAF, MEK, ERK | Proliferation, differentiation, transcriptional regulation | p-ERK, Cyclin D1, EdU, Ki-67 |
PI3K/AKT | PI3K, AKT, mTOR | Survival, migration, anti-apoptosis, metabolic adaptation | p-AKT, p-mTOR, cell viability, apoptosis indicators |
PLCγ/PKC/Ca²⁺ | PLCγ, IP3, DAG, PKC, Ca²⁺ | Ca²⁺ signaling, migration, secretion, cytoskeletal regulation | p-PLCγ, Ca²⁺ changes, PKC activation |
Src/FAK | Src, FAK, Paxillin | Adhesion, chemotaxis, migration, invasion | p-Src, p-FAK, Transwell, cytoskeleton |
STAT-related mechanisms | STAT1, STAT3, STAT5 | Transcriptional regulation, inflammation, cell survival | p-STAT, nuclear translocation, target gene expression |
3 Major Biological Functions of PDGF
3.1 Mitogenic Activity and Cell Proliferation
PDGF is an important mitogen for smooth muscle cells, fibroblasts, connective tissue cells, and bone- and cartilage-related cells. After PDGF stimulation, cells can enter a proliferative state through MAPK, PI3K/AKT, and other mechanisms, showing enhanced DNA synthesis, cell cycle progression, and upregulation of proliferation markers.
(1) Recommended detection
EdU/BrdU incorporation, Ki-67, PCNA, Cyclin D1, cell cycle flow cytometry, p-ERK, and p-AKT.
(2) Interpretation focus
Increased cell number does not necessarily result entirely from enhanced proliferation; it may also result from reduced cell death. To prove that PDGF promotes proliferation, DNA synthesis, cell cycle progression, and apoptosis changes should be evaluated together.
3.2 Chemotaxis and Migration
PDGF can induce fibroblasts, smooth muscle cells, pericytes, and some stromal cells to migrate toward ligand gradients. It is an important chemotactic factor in tissue repair, vascular wall remodeling, and fibrosis.
(1) Recommended detection
Transwell chemotaxis assay, wound healing assay, real-time cell migration analysis, F-actin staining, p-FAK, p-Src, Rac/Rho-related indicators.
(2) Interpretation focus
Accelerated wound closure may result from cell migration or cell proliferation. If chemotaxis is the focus, Transwell assays or migration assays under proliferation-controlled conditions should be prioritized.
3.3 Vascular Maturation and Pericyte Recruitment
The PDGF-BB/PDGFR-β axis is a core topic in vascular maturation research. Endothelial cell-derived PDGF-BB can recruit PDGFR-β-positive pericytes or vascular smooth muscle-like cells, enabling newly formed vessels to acquire supporting structures and reduce abnormal permeability.
(1) Recommended detection
PDGF-BB, PDGFR-β, NG2, α-SMA, Desmin, CD31, pericyte coverage, and vascular permeability.
(2) Interpretation focus
Increased CD31-positive vessel number mainly reflects angiogenesis and does not equal vascular maturation. To demonstrate PDGF-BB involvement in vascular stabilization, pericyte coverage and vascular wall support structures should be detected.
3.4 Tissue Repair and Fibrosis
PDGF can promote fibroblast proliferation, migration, and extracellular matrix production, which is beneficial for wound healing. However, long-term or excessive activation can drive tissue fibrosis and pathological remodeling.
(1) Recommended detection
α-SMA, Collagen I/III, Fibronectin, PDGFR-α/β, p-PDGFR, p-ERK, p-AKT, and tissue collagen deposition.
(2) Interpretation focus
In acute repair, PDGF can promote cell migration and matrix remodeling. In chronic injury, it may promote fibroblast expansion and collagen deposition. Research should distinguish “repair-associated activation” from “pathological fibrosis.”
Table 3 Major Functions of PDGF and Detection Directions
Functional Direction | Main Cell Types | Recommended Detection | Interpretation Focus |
Proliferation promotion | Smooth muscle cells, fibroblasts, stromal cells | EdU, Ki-67, Cyclin D1, p-ERK | Exclude apparent proliferation caused by reduced cell death |
Chemotaxis and migration | Smooth muscle cells, fibroblasts, pericytes | Transwell, p-FAK, p-Src, cytoskeleton | Distinguish migration from proliferation |
Vascular maturation | Pericytes, vascular smooth muscle cells | PDGFR-β, NG2, α-SMA, pericyte coverage | Not equivalent to VEGF-driven simple angiogenesis |
Tissue repair | Fibroblasts, inflammatory cells, vascular wall cells | Collagen deposition, Fibronectin, α-SMA | Acute repair and chronic fibrosis differ in effect |
Developmental regulation | Neural, vascular, and stromal cells | PDGFR-α/β, lineage markers | Interpret according to developmental stage and cell lineage |
4 PDGF-Related Diseases and Application Research
4.1 Tumors and the Tumor Microenvironment
PDGF can act on tumor cells and also on tumor-associated fibroblasts, pericytes, vascular smooth muscle-like cells, and other stromal cells. PDGF-related responses can promote tumor stroma formation, changes in vascular support structures, cell migration, and therapeutic tolerance.
(1) Research focus
PDGF-BB/PDGFR-β is commonly used to study pericyte recruitment and tumor vascular maturation. PDGFR-α abnormalities are often associated with stromal cell activation, proliferation of some tumors, and matrix responses.
(2) Recommended detection
PDGF-AA, PDGF-BB, PDGFR-α, PDGFR-β, p-PDGFR, p-ERK, p-AKT, α-SMA, Collagen I, CD31, NG2, and pericyte coverage.
(3) Interpretation focus
Increased PDGF does not necessarily indicate that tumor cells themselves are driven by PDGF. If PDGFR is mainly expressed in stromal cells or pericytes, it should be interpreted as tumor microenvironment regulation rather than a tumor cell-autonomous proliferation mechanism.
4.2 Vascular Remodeling and Atherosclerosis
PDGF can promote the phenotypic switching of vascular smooth muscle cells from a contractile phenotype to a synthetic phenotype, inducing their proliferation and migration. This process is closely associated with intimal hyperplasia after vascular injury, atherosclerosis, and vascular wall remodeling.
(1) Recommended detection
α-SMA, SM22α, OPN, PCNA, Ki-67, Transwell migration, p-PDGFR-β, p-ERK, and p-AKT.
(2) Interpretation focus
Enhanced smooth muscle cell migration should be interpreted together with phenotypic switching markers. Decreased α-SMA, increased OPN, enhanced migration, and increased proliferation together better support synthetic phenotype transition.
4.3 Fibrotic Diseases
PDGF can promote fibroblast expansion, myofibroblast formation, and extracellular matrix deposition. It is an important growth factor in research on pulmonary fibrosis, liver fibrosis, renal fibrosis, and skin fibrosis.
(1) Recommended detection
PDGFR-α/β, p-PDGFR, α-SMA, Collagen I/III, Fibronectin, p-ERK, p-AKT, and tissue collagen deposition.
(2) Interpretation focus
In fibrosis research, PDGF preferentially drives stromal cell expansion and migration, whereas TGF-β more strongly drives myofibroblast differentiation and matrix production. The two can act synergistically, but their mechanistic positioning differs.
4.4 Neural Development and the Neurovascular Unit
PDGF participates in embryonic neuronal development, oligodendrocyte lineage regulation, and neurovascular unit stability. PDGF-AA/PDGFR-α is associated with oligodendrocyte precursor cell proliferation and differentiation regulation, while PDGF-BB/PDGFR-β is commonly associated with blood-brain barrier pericyte function and neurovascular unit stability.
(1) Recommended detection
PDGFR-α, PDGFR-β, NG2, Olig2, MBP, pericyte markers, blood-brain barrier permeability, and neurological functional recovery indicators.
(2) Interpretation focus
In the nervous system, PDGF functions are cell type-specific. PDGFR-α is more suitable for oligodendrocyte lineage-related interpretation, whereas PDGFR-β is more suitable for pericyte and vascular support cell-related interpretation.
5 Experimental Design and Result Interpretation in PDGF Research
5.1 Ligand Selection
PDGF-AA, PDGF-BB, and PDGF-AB are commonly used for in vitro stimulation experiments. Ligand selection should match receptor expression.
(1) PDGF-AA
PDGF-AA is more suitable for PDGFR-α-positive cells, such as some fibroblasts, oligodendrocyte precursor cells, and stromal cells.
(2) PDGF-BB
PDGF-BB is more suitable for PDGFR-β-positive cells, such as vascular smooth muscle cells, pericytes, and fibroblasts in some fibrosis models.
(3) PDGF-AB
PDGF-AB is suitable for studying mixed PDGFR-α/β-related responses, but the actual response should be confirmed according to receptor expression in the cells.
5.2 Detection Levels
PDGF research should separate short-term receptor activation from long-term functional outputs.
(1) Short-term detection
This is commonly used to determine whether PDGF stimulation activates receptors and downstream mechanisms, including p-PDGFR, p-ERK, p-AKT, p-PLCγ, p-Src, and p-FAK.
(2) Long-term detection
This is used to determine functional outcomes of PDGF, including proliferation, migration, chemotaxis, extracellular matrix production, vascular support structure formation, and tissue repair outcomes.
(3) Dependency validation
To prove that a phenotype is mediated by PDGF-PDGFR, PDGFR inhibitors, neutralizing antibodies, receptor knockdown, or ligand blockade should be used, and synchronous decreases in signaling and functional phenotypes should be observed.
Table 4 PDGF Experimental Design and Interpretation Points
Experimental Purpose | Recommended Design | Key Indicators | Interpretation Focus |
Validating PDGF response | Stimulate target cells with PDGF-AA/BB/AB | p-PDGFR, p-ERK, p-AKT | Confirm receptor subtype expression |
Evaluating proliferation | Detect DNA synthesis and cell cycle after PDGF stimulation | EdU, Ki-67, Cyclin D1 | Exclude the effect of reduced cell death |
Evaluating chemotaxis and migration | Transwell or wound healing assay under proliferation-controlled conditions | Number of migrated cells, p-FAK, cytoskeleton | Proliferation factors should be controlled in wound healing assays |
Evaluating vascular maturation | Endothelial-pericyte coculture or tissue model | PDGFR-β, NG2, α-SMA, pericyte coverage | Distinguish angiogenesis from vascular maturation |
Validating receptor dependence | PDGFR inhibitors, knockdown, or neutralizing antibodies | Decreased p-PDGFR, reversal of functional phenotype | Exclude nonspecific inhibitor effects |
6 PDGF Research-Related Products
Application Module | Cat. No. | Product Name | Grade & Purity | Application Positioning |
PDGF-AA stimulation experiment | Recombinant Human PDGF AA Protein | Carrier Free, Bioactive, ActiBioPure™, High Performance, ≥95%(SDS-PAGE), See COA | For research on PDGFR-α-positive cell proliferation, chemotaxis, oligodendrocyte precursor cells, and fibroblasts | |
PDGF-AA stimulation experiment | Recombinant Human PDGFAA Protein | ≥90%(SDS-PAGE) | For PDGF-AA ligand stimulation, PDGFR-α response, and cell proliferation research | |
PDGF-AB stimulation experiment | Recombinant Human PDGF-AB Protein | Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, His Tag, PBS Only, ≥95%(SDS-PAGE), See COA | For PDGFR-α/β-related stimulation, chemotaxis, and tissue repair models | |
PDGF-AB stimulation experiment | Recombinant Human PDGF-AB Protein | Carrier Free, Bioactive, ActiBioPure™, High Performance, ≥90%(SDS-PAGE), See COA | For PDGF-AB heterodimer activity, cell migration, and receptor response research | |
PDGF-BB stimulation experiment | Recombinant Human PDGF-BB Protein | Carrier Free, Bioactive, ActiBioPure™, High Performance, His Tag, ≥95%(SDS-PAGE), See COA | For PDGFR-β stimulation, smooth muscle cell migration, pericyte recruitment, and fibrosis research | |
PDGF-C research | Recombinant Human PDGFC Protein | Animal Free, Carrier Free, Bioactive, ActiBioPure™, Azide Free, High Performance, His Tag, Fc Tag, ≥95%(SDS-PAGE) | For PDGF-C/PDGFR-α-related mechanisms, development, and tissue remodeling research | |
PDGF-CC research | Recombinant Human PDGF-CC Protein | Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, His Tag, Fc Tag, ≥90%(SDS-PAGE), See COA | For PDGF-CC stimulation, stromal cell responses, and PDGFR-α-related research | |
PDGF-DD research | Recombinant Human PDGFDD Protein | ≥90%(SDS-PAGE) | For PDGF-DD/PDGFR-β-related vascular remodeling, smooth muscle cell responses, and fibrosis research | |
PDGFA-related research | PDGFA | Moligand™ | For PDGFA-related ligand research, mechanism screening, and in vitro cell experiments | |
PDGFB-related research | PDGFB | Moligand™ | For PDGFB-related mechanisms, PDGFR-β response, and vascular wall cell research | |
PDGF-AA-related research | PDGF AA | Moligand™ | For PDGF-AA-related receptor stimulation and functional validation | |
PDGF-AB-related research | PDGF AB | Moligand™ | For PDGF-AB-related cell chemotaxis, repair, and receptor response research | |
PDGF-BB-related research | PDGF BB | Moligand™ | For PDGF-BB-related smooth muscle cell, pericyte, and fibrosis model research | |
GMP-grade PDGF-BB research | Recombinant Human PDGF-BB GMP Protein | Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, ≥75%(SDS-PAGE&SEC-HPLC) | Suitable for PDGF-BB-related cell culture and preclinical translational research requiring higher raw material grade and process control | |
Mouse PDGFB research | Recombinant Mouse PDGFB Protein | ≥90%(SDS-PAGE) | For mouse-derived models, species-matched stimulation, and in vitro mechanism research | |
Rat PDGF-BB research | Recombinant Rat PDGF-BB Protein | Carrier Free, Bioactive, ActiBioPure™, PBS Only, ≥95%(SDS-PAGE), See COA | For rat cell models, vascular smooth muscle cell migration, and tissue repair-related research | |
PDGF-B detection | Recombinant PDGF B Antibody | Recombinant, ExactAb™, Validated, See COA | For PDGF-B protein expression detection and tissue or cell sample validation | |
PDGF-C detection | PDGFC Antibody | Carrier Free, ExactAb™, Validated, 1.0 mg/mL | For PDGF-C expression detection, immunoassays, and tissue localization research | |
Total PDGF detection | Human Platelet Derived Growth Factor (PDGF) ELISA Kit | BioReagent | For detecting PDGF levels in human samples | |
Total PDGF detection | Mouse Platelet Derived Growth Factor (PDGF) ELISA Kit | BioReagent | For detecting PDGF levels in mouse samples | |
PDGF-CC detection | Human Platelet Derived Growth Factor CC (PDGF-CC) ELISA Kit | BioReagent | For quantitative detection of PDGF-CC in human samples | |
PDGFA detection | Human Platelet Derived Growth Factor Subunit A (PDGFA) ELISA Kit | BioReagent | For quantitative detection of PDGFA in human samples | |
PDGF-AA detection | Human Platelet Derived Growth Factor AA (PDGFAA) ELISA Kit | BioReagent | For quantitative detection of PDGF-AA in human samples | |
PDGF-AB detection | Human Platelet Derived Growth Factor AB (PDGF-AB) ELISA Kit | BioReagent | For quantitative detection of PDGF-AB in human samples | |
PDGFB detection | Human Platelet Derived Growth Factor Subunit B (PDGFB) ELISA Kit | BioReagent | For quantitative detection of PDGFB in human samples | |
PDGF-C detection | Human Platelet Derived Growth Factor C (PDGF-C) ELISA Kit | BioReagent | For quantitative detection of PDGF-C in human samples | |
PDGFD detection | Human Platelet Derived Growth Factor D (PDGFD) ELISA Kit | BioReagent | For quantitative detection of PDGFD in human samples | |
PDGF-BB detection | Human Platelet Derived Growth Factor BB (PDGF-BB) ELISA Kit | BioReagent | For quantitative detection of PDGF-BB in human samples | |
Rat PDGFA detection | Rat Platelet Derived Growth Factor Subunit A (PDGFA) ELISA Kit | BioReagent | For quantitative detection of PDGFA in rat samples | |
Rat PDGF-B detection | Rat Platelet Derived Growth Factor Subunit B (PDGF-B) ELISA Kit | BioReagent | For quantitative detection of PDGF-B in rat samples | |
Mouse PDGFA detection | Mouse Platelet Derived Growth Factor Subunit A (PDGFA) ELISA Kit | BioReagent | For quantitative detection of PDGFA in mouse samples | |
Mouse PDGFB detection | Mouse Platelet Derived Growth Factor Subunit B (PDGFB) ELISA Kit | BioReagent | For quantitative detection of PDGFB in mouse samples | |
Mouse PDGF-BB detection | Mouse Mini Samples for Platelet Derived Growth Factor BB (PDGF-BB) ELISA Kit | BioReagent | For quantitative detection of PDGF-BB in mouse samples |
7 Common Questions in PDGF Research
7.1 Does Increased PDGF-BB Equal Enhanced Angiogenesis?
Not necessarily. PDGF-BB more commonly reflects pericyte recruitment, vascular wall support cell responses, and vascular maturation. To prove enhanced angiogenesis, endothelial cell indicators, tube formation, the number of CD31-positive vessels, and VEGF/VEGFR-related indicators should also be detected.
7.2 Is PDGF-Promoted Migration Necessarily ERK-Dependent?
Not necessarily. PDGF-induced migration can involve PI3K/AKT, PLCγ, Src/FAK, Rac/Rho, and cytoskeletal remodeling. Increased ERK only indicates activation of the MAPK branch and cannot independently explain the migration phenotype.
7.3 Does Increased PDGFR Expression Indicate Enhanced PDGF Response?
Not necessarily. Increased total PDGFR protein represents enhanced potential responsiveness, but true receptor activation should be assessed by detecting p-PDGFR and downstream indicators such as p-ERK, p-AKT, p-PLCγ, or p-FAK.
7.4 Does PDGF Play the Same Role in Repair and Fibrosis?
Not exactly. In acute injury, PDGF can promote cell migration, matrix remodeling, and vascular support. In chronic injury, persistent PDGF activation may drive fibroblast expansion, smooth muscle-like transition, and collagen deposition, thereby promoting fibrosis.
PDGF research should establish a mechanistic chain around ligand type, receptor subtype, target cell, and functional output. PDGF-AA, PDGF-BB, PDGF-AB, PDGF-CC, and PDGF-DD differ in their selectivity for PDGFR-α/β, which determines their application differences in studies of proliferation, chemotaxis, vascular maturation, tissue repair, and fibrosis.
References
[1] Lechertier T, Reynolds LE, Kim H, et al. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth. Nat Commun. 2020;11:2810.
[2] Bruveris FF, Ng ES, Stanley EG, et al. VEGF, FGF2, and BMP4 regulate transitions of mesoderm to endothelium and blood cells in a human model of yolk sac hematopoiesis. Exp Hematol. 2021;103:30-39.e2.
危险品化学品经营许可证(带存储)